Works matching AU Wenju Mo


Results: 14
    1
    2
    3
    4

    Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

    Published in:
    Oncology Research & Treatment, 2023, v. 46, n. 7/8, p. 303, doi. 10.1159/000531492
    By:
    • Ding, Yuqin;
    • Mo, Wenju;
    • Xie, Xiaohong;
    • Wang, Ouchen;
    • He, Xiangming;
    • Zhao, Shuai;
    • Gu, Xidong;
    • Liang, Chenlu;
    • Qin, Chengdong;
    • Ding, Kaijing;
    • Yang, Hongjian;
    • Ding, Xiaowen
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14